Apeiron Investment Group Ltd. - 24 Jan 2025 SCHEDULE 13D/A Report for Neuphoria Therapeutics Inc. Common Stock (NEUP)

Filing Manager
Apeiron Investment Group Ltd.
Reporting Manager
Apeiron Investment Group Ltd.
Security
Neuphoria Therapeutics Inc. Common Stock
Symbol
NEUP
Shares outstanding
1,613,733 shares
Disclosed Ownership
72,618 shares
Ownership
4.5%
Form type
SCHEDULE 13D/A
Filing time
28 Jan 2025, 16:30:04 UTC
Date of event
24 Jan 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Apeiron Investment Group Ltd. 4.5% 72,618 0 72,618 /s/ Mario Frendo Mario Frendo, Director 0001845711
Apeiron Presight Capital Fund II, L.P. 0% 0 0 0 By: Presight Capital Management I, L.L.C., its general partner; /s/ Fabian Hansen Fabian Hansen, Managing Member 0001840676
Presight Capital Management I, L.L.C. 0% 0 0 0 /s/ Fabian Hansen Fabian Hansen, Managing Member
Fabian Hansen 0% 0 0 0 /s/ Fabian Hansen Fabian Hansen
Christian Angermayer 4.5% 72,618 0 72,618 /s/ Christian Angermayer Christian Angermayer 0001845872